October 29, 2020 | Blog
2020 USA Election & Drug Pricing Outlook
An analysis of the key drug pricing proposals in the 2020 USA Election in terms of political focus, party priorities, implementation feasibility, and potential risk to biopharma.
Jay Galli
Senior Analyst
Jay Galli is a Senior Analyst at CBPartners.
Connect with Jay Galli
Published Articles
May 18, 2020 | Research posters
ISPOR Annual 2020: The Resultant Impact of HEOR Data on US Payer Formulary Coverage
A research poster identifying instances where manufacturer HEOR data and/or pharmacoeconomic models either influenced positive changes, or had limited tangible impact on resultant US payer coverage decisions.
March 26, 2020 | Podcasts
CBPartners’ Pharma Take-Away: Cell and Gene Therapy Roundtable
In this episode, our host Jared Wolff is joined by healthcare consultants Sophie Katz (a core member of CBPartners' Cell and Gene Therapy Center of Excellence), and Jay Galli to discuss some interesting topics surrounding cell and gene therapies.